Table 5.
Follow-up data.
| Variable | Myocarditis (n = 15) | MINOCA (n = 14) | Takotsubo Cardiomyopathy (n = 9) | All Patients (n = 38) | Healthy Controls (n = 12) | p-Value * |
|---|---|---|---|---|---|---|
| Follow-up | 15 (100%) | 14 (100%) | 9 (100%) | 38 (100%) | 12 (100.0%) | 1.000 |
| ER admissions | 8 (53.3%) | 8 (57.1%) | 0 (0.0%) | 16 (42.1%) | 0 (0.0%) | <0.001 |
| In-hospital admissions | 4 | 4 | 0 | 8 | 0 | <0.001 |
| Chest pain | 3 (20.0%) | 2 (14.2%) | 0 (0.0%) | 5 (13.1%) | 0 (0.0%) | 0.167 |
| ACS | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Arrhythmias | 1 (6.67%) | 2 (7.1%) | 0 (0.0%) | 2 (5.3%) | 0 (0.0%) | 0.402 |
| Syncope | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Death | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 |
* All patients vs. healthy controls.